Agilent (A) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended January 2026, Agilent Technologies (A) reported revenue of $1.8 billion, up 7% over the same period last year. EPS came in at $1.36, compared to $1.31 in the year-ago quarter.The reported revenue represents a surprise of -0.27% over the Zacks Consensus Estimate of $1.8 billion. With the consensus EPS estimate being $1.37, the EPS surprise was -0.52%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Revenue- Americas: $678 million versus the three-analyst average estimate of $704.33 million. The reported number represents a year-over-year change of +1.4%.Net Revenue- Asia Pacific: $602 million versus $604.9 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +9.7% change.Net Revenue- Europe: $518 million versus $486.16 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.9% change.Net Revenue- Life Sciences and Diagnostics Markets Segment: $679 million versus the six-analyst average estimate of $699.9 million.Net Revenue- Applied Markets: $361 million versus $354.15 million estimated by six analysts on average.Net Revenue- Agilent Crosslab Group: $758 million compared to the $748.58 million average estimate based on six analysts.Revenue by End Markets- Chemical and advanced materials: $422 million versus the three-analyst average estimate of $413.46 million. The reported number represents a year-over-year change of +11.4%.Revenue by End Markets- Environmental and Forensics: $177 million versus the three-analyst average estimate of $173.75 million. The reported number represents a year-over-year change of +2.9%.Revenue by End Markets- Diagnostics and Clinical: $263 million versus $254.2 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change.Revenue by End Markets- Academia and Government: $130 million versus $144.5 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -5.1% change.Revenue by End Markets- Pharmaceutical: $640 million versus the three-analyst average estimate of $633.34 million. The reported number represents a year-over-year change of +9.4%.Revenue by End Markets- Food: $166 million versus $166.52 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.2% change.View all Key Company Metrics for Agilent here>>>Shares of Agilent have returned -8.5% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilent Technologies, Inc. (A): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks